NI Data included and NICR included in Concord Workshop, Claudia Allemani, Tomohiro Matsuda, Veronica Di Carlo,… Michel P Coleman, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018; 391:1023-1075 January 2018. doi.org/10.1016/S0140-6736(17)33326-3. Implications of Research.

Minicozzi P, Innos K, Sánchez M-J, Trama A, … , Gavin A, Fitzpatrick D, et al. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study. Eur J Cancer 2017; 84:335-353. doi:10.1016/j.ejca.2017.07.015

Storm H, Engholm G, Mägi M, Aareleid T, … , Gavin A, Donnelly C, et al. Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer 2017; 82:137-148. doi:10.1016/j.ejca.2017.05.028

Dal Maso L, Tavilla A, Pacini F, Serraino D, … , Gavin A, Donnelly C, et al. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 2017; 77:140-152. doi:10.1016/j.ejca.2017.02.023

Rose PW, Rubin G, Perera-Salazar R, Almberg SS, Barisic A, Dawes M, Grunfeld E, Hart N, Neal RD, Pirotta M, Sisler J, Konrad G, Toftegaard BS, Thulesius H, Vedsted P, Young J, Hamilton W, The ICBP Module 3 Working Group* (*includes Dr Anna Gavin).  Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.  BMJ Open 2015; 5:e007212 doi:10.1136/bmjopen-2014-007212 (IF 2.271) 

Crocetti E, Mallone S, Eid Robsahm T, Gavin A, Agius D, Ardanaz E,  Chirlaque Lopez MD, Innos K, Minicozzi P, Borgognoni L, Pierannunzio D, Eisemann N and the EUROCARE-5 Working Group. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study.  European Journal of Cancer 2015; 51: Issue 15; 2179–2190 doi:10.1016/j.ejca.2015.07.039 (IF 5.417). 

Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, et al and the EUROCARE-5 Working Group. The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods.   European Journal of Cancer 2015; 51: 15; 2104–2119; doi:10.1016/j.ejca.2015.08.001 

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Silva GAE, Chen W, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP, the CONCORD Working Group.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.

Rose PW, Rubin G, Perera-Salazar R, Almberg SS, Barisic A, Dawes M, Grunfeld E, Hart N, Neal RD, Pirotta M, Sisler J, Konrad G, Toftegaard BS, Thulesius H, Vedsted P, Young J, Hamilton W, The ICBP Module 3 Working Group* (*includes Dr Anna Gavin).  Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.  BMJ Open May 2015;5:e007212 doi:10.1136/bmjopen-2014-007212 (IF 2.271)

Baili, Paolo; Di Salvo, Francesca; ...; Gavin A; Fitzpatrick D et al. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: results of EUROCARE-5, a population-based study. European journal of cancer October 2015,5. doi.org/10.1016/j.ejca.2015.07.025

Forbes LJ, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C, Haynes K, Hvidberg L, Lagerlung M, Lockwood G, Tishelman C, Vedested P, Vigmostad MN, Ramirez AJ, Wardle J.  International Cancer Benchmarking Partnership Module 2 Working Group.  Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?  British Journal of Cancer, 2013, 108, 292–300. doi:10.1038/bjc.2012.542

Santin O, Mills M, Treanor C, Donnelly M.  A comparative analysis of the health and wellbeing of cancer survivors to the general population. Supportive Care in Cancer. January 2012, doi: 10.1007/s00520-011-1372-9

Coleman MP, Rachet B, Woods L, Gavin AT et al.  Rebuttal to editorial saying cancer survival statistics are misleading (Letter).  BMJ Vol. 343, No. 7814, d4214, 09.07.2011, p. 1-2,  BMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4522 (Published 15 July 2011

Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA and the ICBP Module 1 Working Group.  Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.  The Lancet, January 2011, doi:10.1016/S0140-6736(10)62231-3.

Woods LM, Bernard R, Shack L, Catney D, Walsh PM, Cooper N, White C, Mak V, Stewart J, Comber H, Gavin A, Brewster D, Quinn M, Coleman MP. Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth century. Association Of Cancer Registries, U.K. Health Statistics Quarterly Vol. 46, BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c4112 (Published 11 August 2010)

McMullan EA, Kee F, Patterson CC, Gavin AT, Dolan OM. Improving survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98). British Journal of Dermatology, onlin September 2004 Sep, DOI: 10.1111/j.1365-2133.2004.06071.x